Carregant...
Long term response to erlotinib in a patient with recurrent vulvar carcinoma: Case report and review of literature()
► We report a case of recurrent vulvar carcinoma with a good response to erlotinib. ► Treatment was well tolerated with no serious side effects. ► Further evaluation of this new therapeutic approach may be warranted.
Guardat en:
| Autors principals: | , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Elsevier
2012
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3861161/ https://ncbi.nlm.nih.gov/pubmed/24371640 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.gynor.2012.07.002 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|